UBS downgrades PagSeguro stock rating on rate concerns

UBS downgraded PagSeguro to Neutral from Buy and cut its price target to $8 from $13, citing higher-for-longer rates, softer payment-volume growth and credit headwinds. UBS estimates each 100-basis-point increase in policy rates could reduce earnings by about R$360 million, or roughly 14% of its 2027 estimate; the total credit book was down 3% versus UBS expectations, while cost of risk rose from 3.6% in Q3 2025 to 5.6% in Q2 2026. Shares were at $7.92, near their $7.50 52-week low; separate InvestingPro data described the stock as potentially undervalued and its RSI as oversold.

Analysis

The key risk is earnings sensitivity running through two channels at once: higher funding costs pressure acquiring economics, while weaker credit growth and rising losses limit the usual offset from expanding the loan book. If PagSeguro responds to funding pressure with higher merchant pricing, the second-order risk is volume leakage to competitors such as StoneCo or Mercado Pago; if it tightens credit instead, merchant engagement and cross-sell may weaken. The reported rate sensitivity is a UBS model estimate, not a fixed hedge ratio, and should be tested against actual funding mix, repricing lag and credit performance.

The low P/E and oversold signal are not, by themselves, evidence of mispricing: if earnings estimates have not yet absorbed higher credit costs, the multiple may be applied to an overstated earnings base. Conversely, a sharp rate reversal could make the stock’s rate sensitivity work quickly in its favor. Near term, the 52-week low is a positioning/technical level, not a valuation floor. Over 1–3 months, focus on Brazilian rate expectations, payment-volume trends and credit-loss disclosures; over 6–18 months, merchant retention and realized loan losses determine whether the business can defend returns through the cycle. Verify the timing and estimate basis of UBS’s conflicting rating/target updates before treating them as a clean change in stance.

Key Decisions for Investors

• Do not chase an outright short at current levels: the downside thesis is credible, but proximity to the 52-week low and potential rate relief create squeeze risk. Keep PAGS underweight pending evidence that credit costs have peaked.
• For a defined-risk bearish expression, consider a put spread only after a confirmed close below $7.50, with loss capped at the premium and position sized for a possible rebound. Invalidate the setup on a sustained recovery above that level alongside improving payment volume or lower credit losses; check option liquidity and pricing first.
• Treat a sustained decline in cost of risk, stabilizing portfolio growth and improving TPV as the key falsifiers. If those appear while Brazilian rate expectations ease, reassess rather than relying on the low reported P/E as a short signal.
• Alert: reconcile the dates and estimate bases behind UBS’s Neutral/$8 and earlier Buy/$11 references, and monitor actual funding costs, pricing pass-through, TPV and credit-loss metrics at the next results. Without that reconciliation, avoid trading the analyst revision alone.